参考文献

[1] Devita VT Jr,Rosenberg SA.Two hundred years of cancer research.N Engl J Med,2012,366(23):2207-2214.

[2] Hanahan D,Weinberg RA.Hallmarks of cancer:the next generation.Cell,2011,144(5):646-674.

[3] Uchino K,Tateishi R,Shiina S,et al.Hepatocellular carcinoma with extrahepatic metastasis:clinical features and prognostic factors.Cancer,2011,117(19):4475-4483.

[4] Ye QH,Qin LX,Forgues M,et al.Predicting hepatitis B virus-positive metastatic hepatocellular carcinomas using gene expression profiling and supervised machine learning.Nat Med,2003,9(4):416-423.

[5] Yamashita T,Ji J,Budhu A,et al.EpCAM-positive hepatocellular carcinoma cells are tumor-initiating cells with stem/progenitor cell features.Gastroenterology,2009,136(3):1012-1024.

[6] Jia QA,Ren ZG,Bu Y,et al.Herbal Compound “Songyou Yin” Renders Hepatocellular Carcinoma Sensitive to Oxaliplatin through Inhibition of Stemness.Evid Based Complement Alternat Med,2012,2012:908601.

[7] Budhu A,Forgues M,Ye QH,et al.Prediction of venous metastases,recurrence,and prognosis in hepatocellular carcinoma based on a unique immune response signature of the liver microenvironment.Cancer Cell,2006,10(2):99-111.

[8] Malanchi I,Santamaria-Martinez A,Susanto E,et al.Interactions between cancer stem cells and their niche govern metastatic colonization.Nature,2012,7379(481):85-89.

[9] Jia QA, Wang ZM, Ren ZG, et al.Herbal compound “Songyou Yin” attenuates hepatoma cell invasiveness and metastasis through downregulation of cytokines secreted by activated hepatic stellate cells.BMC Complement Altern Med,2013,13:89.

[10] Yamauchi K,Yang M,Hayashi K,et al.Induction of cancer metastasis by cyclophosphamide pretreatment of host mice:an opposite effect of chemotherapy.Cancer Res,2008,68(2):516-520.

[11] Altekruse SF,Mcglynn KA,Dickie LA,et al.Hepatocellular carcinoma confirmation,treatment,and survival in surveillance,epidemiology,and end results registries,1992-2008.Hepatology,2012,55(2):476-482.

[12] Santi V,Buccione D,Di Micoli A,et al.The changing scenario of hepatocellular carcinoma over the last two decades in Italy.J Hepatol,2012,56(2):397-405.

[13] Kim YS,Lim HK,Rhim H,et al.Ten-year outcomes of percutaneous radiofrequency ablation as first-line therapy of early hepatocellular carcinoma:analysis of prognostic factors.J Hepatol,2013,58(1):89-97.

[14] Pang JZ,Qin LX,Ren N,et al.Loss of heterozygosity at D8S298 is a predictor for long-term survival of patients with tumor-node-metastasis stage I of hepatocellular carcinoma.Clin Cancer Res,2007,24(13):7363-7369.

[15] Huang XY,Huang ZL,Wang L,et al.Herbal compound “Songyou Yin” reinforced the ability of interferon-alfa to inhibit the enhanced metastatic potential induced by palliative resection of hepatocellular carcinoma in nude mice.BMC Cancer,2010,10:580.

[16] Tang ZY,Yu YQ,Zhou XD,et al.Cytoreduction and sequential resection:a hope for unresectable primary liver cancer.J Surg Oncol,1991,47(1):27-31.

[17] Zaanan A,Williet N,Hebbar M,et al.Gemcitabine plus oxaliplatin in advanced hepatocellular carcinoma:a large multicenter AGEO study.J Hepatol,2013,58(1):81-88.

[18] Feng YX,Wang T,Deng YZ,et al.Sorafenib suppresses postsurgical recurrence and metastasis of hepatocellular carcinoma in an orthotopic mouse model.Hepatology,2011,53(2):483-492.

[19] Wang L,Tang ZY,Qin LX,et al.High-dose and long-term therapy with interferon-alfa inhibits tumor growth and recurrence in nude mice bearing human hepatocellular carcinoma xenografts with high metastatic potential.Hepatology,2000,32(1):43-48.

[20] Sun HC,Tang ZY,Wang L,et al.Postoperative interferon alpha treatment postponed recurrence and improved overall survival in patients after curative resection of HBV-related hepatocellular carcinoma:a randomized clinical trial.J Cancer Res Clin Oncol,2006,132(7):458-465.

[21] Eltzschig HK,Carmeliet P.Hypoxia and inflammation.N Engl J Med,2011,364(7):656-665.

[22] Dinarello CA.Anti-inflammatory Agents:Present and Future.Cell,2010,140(6):935-950.

[23] Sahasrabuddhe VV,Gunja MZ,Graubard BI,et al.Nonsteroidal anti-inflammatory drug use,chronic liver disease,and hepatocellular carcinoma.J Natl Cancer Inst,2012,104(23):1808-1814.

[24] Hsu YC,Ho HJ,Wu MS,et al.Postoperative peg-interferon plus ribavirin is associated with reduced recurrence of hepatitis C virus-related hepatocellular carcinoma.Hepatology,2013,58(1):150-157.

[25] Zhang XW,Yan XJ,Zhou ZR,et al.Arsenic trioxide controls the fate of the PML-RARalpha oncoprotein by directly binding PML.Science,2010,5975(328):240-243.

[26] Wang WQ,Liu L,Sun HC,et al.Tanshinone IIA inhibits metastasis after palliative resection of hepatocellular carcinoma and prolongs survival in part via vascular normalization.J Hematol Oncol,2012,5:69.

[27] Liu L,Ren ZG,Shen Y,et al.Influence of hepatic artery occlusion on tumor growth and metastatic potential in a human orthotopic hepatoma nude mouse model:relevance of epithelial-mesenchymal transition.Cancer Sci,2010,101(1):120-128.

[28] Liu L,Zhu XD,Wang WQ,et al.Activation of beta-catenin by hypoxia in hepatocellular carcinoma contributes to enhanced metastatic potential and poor prognosis.Clin Cancer Res,2010,16(10):2740-2750.

[29] Sun FX,Tang ZY,Lui KD,et al.Establishment of a metastatic model of human hepatocellular carcinoma in nude mice via orthotopic implantation of histologically intact tissues.Int J Cancer,1996,66(2):239-243.

[30] Tian J,Tang ZY,Ye SL,et al.New human hepatocellular carcinoma(HCC)cell line with highly metastatic potential(MHCC97)and its expressions of the factors associated with metastasis.Br J Cancer,1999,81(5):814-821.

[31] Li T,Zeng ZC,Wang L,et al.Radiation enhances longterm metastasis potential of residual hepatocellular carcinoma in nude mice through TMPRSS4-induced epithelialmesenchymal transition.Cancer Gene Ther,2011,18(9):617-626.

[32] Xiong W,Ren ZG,Qiu SJ,et al.Residual hepatocellular carcinoma after oxaliplatin treatment has increased metastatic potential in a nude mouse model and is attenuated by Songyou Yin.BMC Cancer,2010,10:219.

[33] Zhang W,Sun HC,Wang WQ,et al.Sorafenib down-regulates expression of HTATIP2 to promote invasiveness and metastasis of orthotopic hepatocellular carcinoma tumors in mice.Gastroenterology,2012,143(6):1641-1649.

[34] Zhang QB,Sun HC,Zhang KZ,et al.Suppression of natural killer cells by sorafenib contributes to prometastatic effects in hepatocellular carcinoma.PLoS One,2013,8(2):E5945.

[35] Zhu XD,Sun HC,Xu HX,et al.Antiangiogenic therapy promoted metastasis of hepatocellular carcinoma by suppressing host-derived interleukin-12b in mouse models.Angiogenesis,2013,16(4):809-820.

[36] Huang Q,Li F,Liu X,et al.Caspase 3-mediated stimulation of tumor cell repopulation during cancer radiotherapy.Nat Med,2011,17(7):860-866.

[37] Casanovas O.Cancer:Limitations of therapies exposed.Nature,2012,7392(484):44-46.

[38] Zhang W,Zhu XD,Sun HC,et al.Depletion of tumor-associated macrophages enhances the effect of sorafenib in metastatic liver cancer models by antimetastatic and antiangiogenic effects.Clin Cancer Res,2010,16(13):3420-3430.

[39] Huang XY,Wang L,Huang ZL,et al.Herbal extract “Songyou Yin” inhibits tumor growth and prolongs survival in nude mice bearing human hepatocellular carcinoma xenograft with high metastatic potential.J Cancer Res Clin Oncol,2009,135(9):1245-1255.

[40] Jia JB,Wang WQ,Sun HC,et al.A novel tripeptide,tyroserleutide,inhibits irradiation-induced invasiveness and metastasis of hepatocellular carcinoma in nude mice.Invest New Drugs,2011,29(5):861-872.

[41] Entschladen F,Drell TLT,Lang K,et al.Tumour-cell migration,invasion,and metastasis:navigation by neurotransmitters.Lancet Oncol,2004,5(4):254-258.

[42] Ondicova K,Mravec B.Role of nervous system in cancer aetiopathogenesis.Lancet Oncol,2010,11(6):596-601.

[43] Schreiber RD,Old LJ,Smyth MJ.Cancer immunoediting:integrating immunity’s roles in cancer suppression and promotion.Science,2011,6024(331):1565-1570.

[44] Weiner LM,Murray JC,Shuptrine CW.Antibody-based immunotherapy of cancer.Cell,2012,148(6):1081-1084.

[45] Joshi PA,Jackson HW,Beristain AG,et al.Progesterone induces adult mammary stem cell expansion.Nature,2010,7299(465):803-807.

[46] Israelsen WJ,Vander Heiden MG.ATP consumption promotes cancer metabolism.Cell,2010,143(5):669-671.

[47] Nieman KM,Kenny HA,Penicka CV,et al.Adipocytes promote ovarian cancer metastasis and provide energy for rapid tumor growth.Nat Med,2011,17(11):1498-1503.

[48] Garcia-Cao I,Song MS,Hobbs RM,et al.Systemic elevation of PTEN induces a tumor-suppressive metabolic state.Cell,2012,149(1):49-62.

[49] Krall AS,Christofk HR.Cancer:A metabolic metamorphosis.Nature,2013,7443(496):38-40.

[50] Ji J,Shi J,Budhu A,et al.MicroRNA expression,survival,and response to interferon in liver cancer.N Engl J Med,2009,361(15):1437-1447.